160 related articles for article (PubMed ID: 8821696)
1. Expression of proliferating cell nuclear antigen and deoxyribonucleic acid value in renal cell carcinoma: correlation with different histopathological parameters and patient survival.
Shameem IA; Shimabukuro T; Wada T; Kurisu H; Naito K
Eur Urol; 1996; 29(1):78-84. PubMed ID: 8821696
[TBL] [Abstract][Full Text] [Related]
2. [Proliferating cell nuclear antigen expression as a prognostic indicator for renal cell carcinoma: comparison with pathologic features and DNA content].
Nakano S; Kawamura J
Hinyokika Kiyo; 1995 May; 41(5):343-8. PubMed ID: 7598033
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of ploidy and proliferation markers in renal cell carcinoma.
Tannapfel A; Hahn HA; Katalinic A; Fietkau RJ; Kühn R; Wittekind CW
Cancer; 1996 Jan; 77(1):164-71. PubMed ID: 8630925
[TBL] [Abstract][Full Text] [Related]
4. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
5. [Usefulness of DNA ploidy, AgNORs, PCNA and c-erbB-2 as predictors of prognosis in patients with renal cell carcinoma].
Tamaki M; Maeda S; Deguchi T; Kawada Y
Hinyokika Kiyo; 1997 Oct; 43(10):697-702. PubMed ID: 9395903
[TBL] [Abstract][Full Text] [Related]
6. Proliferating cell nuclear antigen expression in renal cell carcinoma. Prognostic implications.
Larsson P; Roos G; Stenling R; Ljungberg B
Scand J Urol Nephrol; 1996 Dec; 30(6):445-50. PubMed ID: 9008023
[TBL] [Abstract][Full Text] [Related]
7. DNA and PCNA content of renal cell carcinoma and prognosis.
Flint A; Grossman HB; Liebert M; Lloyd RV; Bromberg J
Am J Clin Pathol; 1995 Jan; 103(1):14-9. PubMed ID: 7817936
[TBL] [Abstract][Full Text] [Related]
8. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
9. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
11. Proliferating cell nuclear antigen (PCNA) as a prognostic factor in renal cell carcinoma.
Morell-Quadreny L; Clar-Blanch F; Fenollosa-Enterna B; Perez-Bacete M; Martinez-Lorente A; Llombart-Bosch A
Anticancer Res; 1998; 18(1B):677-82. PubMed ID: 9584051
[TBL] [Abstract][Full Text] [Related]
12. Intranuclear localization of proliferating cell nuclear antigen during the cell cycle in renal cell carcinoma.
Kawamura K; Kobayashi Y; Tanaka T; Ikeda R; Fujikawa-Yamamoto K; Suzuki K
Anal Quant Cytol Histol; 2000 Apr; 22(2):107-13. PubMed ID: 10800611
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric assessment of deoxyribonucleic acid content in renal adenocarcinoma: does ploidy status enhance prognostic stratification over stage alone?
Currin SM; Lee SE; Walther PJ
J Urol; 1990 Mar; 143(3):458-63. PubMed ID: 2304153
[TBL] [Abstract][Full Text] [Related]
14. [Expression of proliferating cell nuclear antigen (PCNA) in renal cell carcinoma].
Seki H; Nagamori S; Koyanagi T
Nihon Hinyokika Gakkai Zasshi; 1995 Sep; 86(9):1475-82. PubMed ID: 7474637
[TBL] [Abstract][Full Text] [Related]
15. Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Correlation with tumor progression and survival.
Nakamura T; Tabuchi Y; Nakae S; Ohno M; Saitoh Y
Cancer; 1996 Apr; 77(8 Suppl):1741-6. PubMed ID: 8608572
[TBL] [Abstract][Full Text] [Related]
16. Prognostic biomarkers in renal cell carcinoma: relevance of DNA ploidy in predicting disease-related survival.
Pinto AE; Monteiro P; Silva G; Ayres JV; Soares J
Int J Biol Markers; 2005; 20(4):249-56. PubMed ID: 16398407
[TBL] [Abstract][Full Text] [Related]
17. [Qualitative and quantitative parameters for prognosis in renal carcinoma in early and advanced stages].
Del Vecchio MT; Spina D; Lazzi S; Bruni A; Funtò I; Mattei FM; Fornaini M; Luzi P; Tosi P
Pathologica; 1997 Aug; 89(4):390-6. PubMed ID: 9471607
[TBL] [Abstract][Full Text] [Related]
18. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
Larsson P
Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
[TBL] [Abstract][Full Text] [Related]
19. Transitional cell carcinoma of the renal pelvis and ureter: prognostic relevance of nuclear deoxyribonucleic acid ploidy studied by slide cytometry: an 8-year survival time study.
al-Abadi H; Nagel R
J Urol; 1992 Jul; 148(1):31-7. PubMed ID: 1613875
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric deoxyribonucleic acid analysis in stage I renal cell carcinoma.
Ljungberg B; Larsson P; Stenling R; Roos G
J Urol; 1991 Sep; 146(3):697-9. PubMed ID: 1875475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
